An RF engineer explains why sensor physics and analog design, not software, determine whether wearable trial data can be trusted.
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
5 Key Takeaways From The FDA's Real-World Evidence Guidance
With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials
A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
-
Paperless Online Remote Source Document Verification
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
How eCOA Improves Patient Experience
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
Electronic Trial Master File: The Metrics
Here, the author defines several key ideas surrounding data, reports, and insights, honing in on one that is uniquely electronic and only possible because of the move to eTMF — Metrics!
-
Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?
If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?
-
Data Distortions: When Statistics Can Lead Us Astray In Drug Safety
Post-marketing signals and AE frequency comparisons need careful interpretation. Discover how confounding factors and misunderstood statistics often mislead drug safety professionals.
-
Enhancing Information Dissemination
By utilizing advanced digital solutions, Medical Affairs (MA) teams can optimize workflows, reduce their operational burdens, and elevate the quality of communication.
-
Why Use Scorecards To Make Vendor Selection Decisions
Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.
-
Oncology Preferences From Patients And Caregivers On Trial Tech
Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
RECENT NEWSLETTERS
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution